Reduces appetite and increases satiety to support sustainable weight management
Enhances insulin sensitivity and reduces post-meal glucose spikes to help maintain healthy glucose levels
Acts on brain pathways that control hunger and food intake
Improved weight and metabolic control may help reduce risk factors associated with cardiometabolic disease
Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone involved in regulating appetite, insulin secretion, and blood sugar levels. By slowing gastric emptying and signaling fullness to the brain, it helps reduce food intake while improving glucose control.
Treatment may be provided as either a commercially available semaglutide product or a compounded formulation prepared by a licensed compounding pharmacy, based on what your clinician determines is most appropriate for your care.
*Only certain dosages are available in CA
Pharmaceutical products are only available to members of the Lifeforce Membership ($149/month) and are contingent on blood tests results and clinician video consult. To qualify for the program you must reside in an eligible state* and purchase a Lifeforce Diagnostic ($599).

A compounded thyroid hormone therapy combining T4 and T3 in ratios to support balanced metabolism, energy production, and thyroid hormone signaling.

Prevent glucose spikes with a tablet that increases insulin sensitivity and disposes of excess glucose in the liver, muscle, fat, and brain.

Fight age-related hormonal decline.

A dual incretin therapy that helps regulate appetite, improve blood sugar control, and support sustainable weight loss.